MX2021015673A - Alteracion de biopelicula. - Google Patents
Alteracion de biopelicula.Info
- Publication number
- MX2021015673A MX2021015673A MX2021015673A MX2021015673A MX2021015673A MX 2021015673 A MX2021015673 A MX 2021015673A MX 2021015673 A MX2021015673 A MX 2021015673A MX 2021015673 A MX2021015673 A MX 2021015673A MX 2021015673 A MX2021015673 A MX 2021015673A
- Authority
- MX
- Mexico
- Prior art keywords
- gram
- methods
- biofilms
- biofilm
- negative bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/20—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom three- or four-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Dermatology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a métodos para dispersar biopelículas que comprenden bacterias Gram-negativas, los métodos comprenden exponer la biopelícula a un compuesto epoxitiglienona o una sal del mismo. También se describen métodos para tratar infecciones que comprenden la administración localizada, por ejemplo, tópicamente o por inyección, de un compuesto de epoxitiglienona en o sobre una biopelícula establecida que comprende bacterias Gram-negativas para alterar la estructura de esa biopelícula y métodos para prevenir biopelículas que comprenden bacterias Gram-negativas que formen o dispersan biopelículas que comprenden biopelículas Gram-negativas que se han formado en los dispositivos médicos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019902144A AU2019902144A0 (en) | 2019-06-19 | Biofilm Disruption | |
| PCT/AU2020/050623 WO2020252535A1 (en) | 2019-06-19 | 2020-06-19 | Biofilm disruption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021015673A true MX2021015673A (es) | 2022-02-03 |
Family
ID=74036856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021015673A MX2021015673A (es) | 2019-06-19 | 2020-06-19 | Alteracion de biopelicula. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220313648A1 (es) |
| EP (1) | EP3986394A4 (es) |
| JP (1) | JP2022537367A (es) |
| KR (1) | KR20220024696A (es) |
| CN (1) | CN114126606A (es) |
| AU (1) | AU2020297184A1 (es) |
| BR (1) | BR112021024716A2 (es) |
| CA (1) | CA3143793C (es) |
| IL (1) | IL289072A (es) |
| MX (1) | MX2021015673A (es) |
| WO (1) | WO2020252535A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1971588T3 (pl) * | 2005-12-23 | 2013-01-31 | Qbiotics Ltd | Pochodne tiglien-3-onu |
| CN113186129B (zh) * | 2021-04-22 | 2023-02-28 | 深圳尧天舜日生物技术有限公司 | 皮肤共生菌及其应用 |
| WO2023115123A1 (en) * | 2021-12-21 | 2023-06-29 | QBiotics Pty Ltd | Crystalline intermediates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1971588T3 (pl) * | 2005-12-23 | 2013-01-31 | Qbiotics Ltd | Pochodne tiglien-3-onu |
| US10183921B2 (en) * | 2013-04-18 | 2019-01-22 | Qbiotics Limited | Methods and compositions for wound healing |
| PL3600281T3 (pl) * | 2017-03-23 | 2023-09-11 | QBiotics Pty Ltd | Terapia skojarzona w leczeniu i profilaktyce nowotworów |
-
2020
- 2020-06-19 MX MX2021015673A patent/MX2021015673A/es unknown
- 2020-06-19 EP EP20826195.8A patent/EP3986394A4/en active Pending
- 2020-06-19 AU AU2020297184A patent/AU2020297184A1/en active Pending
- 2020-06-19 BR BR112021024716A patent/BR112021024716A2/pt unknown
- 2020-06-19 WO PCT/AU2020/050623 patent/WO2020252535A1/en unknown
- 2020-06-19 JP JP2021575431A patent/JP2022537367A/ja active Pending
- 2020-06-19 US US17/620,517 patent/US20220313648A1/en active Pending
- 2020-06-19 KR KR1020227001798A patent/KR20220024696A/ko unknown
- 2020-06-19 CN CN202080052518.3A patent/CN114126606A/zh active Pending
- 2020-06-19 CA CA3143793A patent/CA3143793C/en active Active
-
2021
- 2021-12-16 IL IL289072A patent/IL289072A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN114126606A (zh) | 2022-03-01 |
| KR20220024696A (ko) | 2022-03-03 |
| CA3143793A1 (en) | 2020-12-24 |
| US20220313648A1 (en) | 2022-10-06 |
| IL289072A (en) | 2022-02-01 |
| AU2020297184A1 (en) | 2022-01-27 |
| JP2022537367A (ja) | 2022-08-25 |
| EP3986394A4 (en) | 2022-08-10 |
| BR112021024716A2 (pt) | 2022-02-08 |
| CA3143793C (en) | 2024-01-16 |
| EP3986394A1 (en) | 2022-04-27 |
| WO2020252535A1 (en) | 2020-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021015673A (es) | Alteracion de biopelicula. | |
| MX2023005160A (es) | Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma. | |
| AU2017228405A8 (en) | Small molecule IRE1-alpha inhibitors | |
| CY1122305T1 (el) | Ενωσεις υδροξαζολης υδροξαμικου οξεος ως αναστολεις lpxc | |
| CL2020003276A1 (es) | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias | |
| MX2021006695A (es) | Moduladores de trex1. | |
| ZA202002093B (en) | Antibacterial compounds | |
| PH12019500242A1 (en) | 9-aminomethyl minocycline compounds and uses thereof | |
| ZA202006612B (en) | Antibacterial compounds | |
| ZA202301937B (en) | Compounds | |
| MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
| PH12019502509A1 (en) | Compounds and methods for treating bacterial infections | |
| BR112017021380A2 (pt) | composto, combinação, formulação farmacêutica, método de extermínio e/ou prevenção do crescimento de um protozoário, e, uso de composto | |
| PH12021551058A1 (en) | Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof | |
| PH12021550452A1 (en) | Methods of treating mycobacterial infections using tetracycline compounds | |
| MY183483A (en) | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof | |
| BR112021018084A8 (pt) | Medicamento e método para tratamento ou prevenção de complicações de diabetes usando o mesmo medicamento | |
| PH12020550222A1 (en) | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections | |
| GEP20247590B (en) | Antibacterial quinolines | |
| MX2022003814A (es) | Compuestos antibacterianos de 4-quinolinona. | |
| IN2014DE02523A (es) | ||
| WO2019070709A8 (en) | Compounds for treating or preventing flavivirus infections | |
| WO2019046465A3 (en) | THERAPEUTIC INDOLES | |
| PH12016502547A1 (en) | Methods for treating infections | |
| CY1119316T1 (el) | Υδροχλωρικα αλατα μιας αντιβιοτικης ενωσης |